NEOE:TMO (USA)
Â
Canadian Depository Receipt (CAD Hedged)
C$
21.58
(+0.28%)
Apr 26
Business Description
Thermo Fisher Scientific Inc
NAICS : 541380
SIC : 3826
Share Class Description:
NEOE:TMO: Canadian Depository Receipt (CAD Hedged)Compare
Compare
Traded in other countries / regions
TMO.USATMOS34.BrazilTMO.CanadaTN80.GermanyTMO.MexicoTMO.ArgentinaTMO.Peru1TMO.ItalyTMOF.Austria0R0H.UK IPO Date
2024-02-15Description
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.2 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.78 | |||||
| Debt-to-EBITDA | 3.14 | |||||
| Interest Coverage | 5.1 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.38 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11 | |||||
| 3-Year EBITDA Growth Rate | 4.1 | |||||
| 3-Year EPS without NRI Growth Rate | 3.3 | |||||
| 3-Year FCF Growth Rate | 1.5 | |||||
| 3-Year Book Growth Rate | 11.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 6.63 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.47 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.71 | |||||
| 9-Day RSI | 54.32 | |||||
| 14-Day RSI | 52.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | |||||
| Quick Ratio | 1.33 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 77.97 | |||||
| Days Sales Outstanding | 69.51 | |||||
| Days Payable | 40.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.07 | |||||
| 3-Year Dividend Growth Rate | 16.7 | |||||
| Forward Dividend Yield % | 0.14 | |||||
| 5-Year Yield-on-Cost % | 0.15 | |||||
| 3-Year Average Share Buyback Ratio | 0.8 | |||||
| Shareholder Yield % | 0.4 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.63 | |||||
| Operating Margin % | 17.26 | |||||
| Net Margin % | 14.2 | |||||
| FCF Margin % | 17.79 | |||||
| ROE % | 13.49 | |||||
| ROA % | 6.26 | |||||
| ROIC % | 7.94 | |||||
| ROC (Joel Greenblatt) % | 52.41 | |||||
| ROCE % | 9.72 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.79 | |||||
| Forward PE Ratio | 26.6 | |||||
| PE Ratio without NRI | 28.62 | |||||
| Shiller PE Ratio | 46.95 | |||||
| Price-to-Owner-Earnings | 32.19 | |||||
| PEG Ratio | 1.88 | |||||
| PS Ratio | 5.22 | |||||
| PB Ratio | 4.84 | |||||
| Price-to-Free-Cash-Flow | 29.4 | |||||
| Price-to-Operating-Cash-Flow | 24.89 | |||||
| EV-to-EBIT | 31.06 | |||||
| EV-to-Forward-EBIT | 25.62 | |||||
| EV-to-EBITDA | 21.8 | |||||
| EV-to-Forward-EBITDA | 22.92 | |||||
| EV-to-Revenue | 5.82 | |||||
| EV-to-Forward-Revenue | 5.76 | |||||
| EV-to-FCF | 32.71 | |||||
| Price-to-DCF (Earnings Based) | 0.92 | |||||
| Price-to-DCF (FCF Based) | 1.24 | |||||
| Earnings Yield (Greenblatt) % | 3.22 | |||||
| FCF Yield % | 3.45 | |||||
| Forward Rate of Return (Yacktman) % | 16.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Thermo Fisher Scientific Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 57,114.077 | ||
| EPS (TTM) (C$) | 20.962 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 52.37 | ||
| 14-Day ATR (C$) | 0.290558 | ||
| 20-Day SMA (C$) | 21.464 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 20.31 - 22.59 | ||
| Shares Outstanding (Mil) | 381.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Thermo Fisher Scientific Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Thermo Fisher Scientific Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Thermo Fisher Scientific Inc Frequently Asked Questions
What is Thermo Fisher Scientific Inc(NEOE:TMO)'s stock price today?
The current price of NEOE:TMO is C$21.58. The 52 week high of NEOE:TMO is C$22.59 and 52 week low is C$20.31.
When is next earnings date of Thermo Fisher Scientific Inc(NEOE:TMO)?
The next earnings date of Thermo Fisher Scientific Inc(NEOE:TMO) is .
Does Thermo Fisher Scientific Inc(NEOE:TMO) pay dividends? If so, how much?
The Dividend Yield %  of Thermo Fisher Scientific Inc(NEOE:TMO) is 0.07% (As of Today), Highest Dividend Payout Ratio of Thermo Fisher Scientific Inc(NEOE:TMO) was 0.18. The lowest was 0.04. And the median was 0.09. The  Forward Dividend Yield % of Thermo Fisher Scientific Inc(NEOE:TMO) is 0.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers